Rabbit derived VL single-domains as promising scaffolds to generate antibody-drug conjugates. 2023

Ana S André, and Joana N R Dias, and Sandra Aguiar, and Sara Nogueira, and Pedro Bule, and Joana Inês Carvalho, and João P M António, and Marco Cavaco, and Vera Neves, and Soraia Oliveira, and Gonçalo Vicente, and Belmira Carrapiço, and Berta São Braz, and Barbara Rütgen, and Lurdes Gano, and João D G Correia, and Miguel Castanho, and Joao Goncalves, and Pedro M P Gois, and Solange Gil, and Luís Tavares, and Frederico Aires-da-Silva
CIISA-Centre for Interdisciplinary Research in Animal Health, Faculty of Veterinary Medicine, University of Lisbon, Avenida da Universidade Técnica, 1300-477, Lisbon, Portugal.

Antibody-drug conjugates (ADCs) are among the fastest-growing classes of therapeutics in oncology. Although ADCs are in the spotlight, they still present significant engineering challenges. Therefore, there is an urgent need to develop more stable and effective ADCs. Most rabbit light chains have an extra disulfide bridge, that links the variable and constant domains, between Cys80 and Cys171, which is not found in the human or mouse. Thus, to develop a new generation of ADCs, we explored the potential of rabbit-derived VL-single-domain antibody scaffolds (sdAbs) to selectively conjugate a payload to Cys80. Hence, a rabbit sdAb library directed towards canine non-Hodgkin lymphoma (cNHL) was subjected to in vitro and in vivo phage display. This allowed the identification of several highly specific VL-sdAbs, including C5, which specifically target cNHL cells in vitro and present promising in vivo tumor uptake. C5 was selected for SN-38 site-selective payload conjugation through its exposed free Cys80 to generate a stable and homogenous C5-DAB-SN-38. C5-DAB-SN-38 exhibited potent cytotoxicity activity against cNHL cells while inhibiting DNA-TopoI activity. Overall, our strategy validates a platform to develop a novel class of ADCs that combines the benefits of rabbit VL-sdAb scaffolds and the canine lymphoma model as a powerful framework for clinically translation of novel therapeutics for cancer.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077146 Irinotecan A semisynthetic camptothecin derivative that inhibits DNA TOPOISOMERASE I to prevent nucleic acid synthesis during S PHASE. It is used as an antineoplastic agent for the treatment of COLORECTAL NEOPLASMS and PANCREATIC NEOPLASMS. 7-Ethyl-10-hydroxycamptothecin,CPT 11,CPT-11,Camptosar,Camptothecin-11,Irinotecan Hydrochloride,Irrinotecan,NK012 Compound,SN 38,SN 38 11,SN-38,SN-38-11,7 Ethyl 10 hydroxycamptothecin,CPT11,Camptothecin 11,SN3811
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Ana S André, and Joana N R Dias, and Sandra Aguiar, and Sara Nogueira, and Pedro Bule, and Joana Inês Carvalho, and João P M António, and Marco Cavaco, and Vera Neves, and Soraia Oliveira, and Gonçalo Vicente, and Belmira Carrapiço, and Berta São Braz, and Barbara Rütgen, and Lurdes Gano, and João D G Correia, and Miguel Castanho, and Joao Goncalves, and Pedro M P Gois, and Solange Gil, and Luís Tavares, and Frederico Aires-da-Silva
February 2020, Scientific reports,
Ana S André, and Joana N R Dias, and Sandra Aguiar, and Sara Nogueira, and Pedro Bule, and Joana Inês Carvalho, and João P M António, and Marco Cavaco, and Vera Neves, and Soraia Oliveira, and Gonçalo Vicente, and Belmira Carrapiço, and Berta São Braz, and Barbara Rütgen, and Lurdes Gano, and João D G Correia, and Miguel Castanho, and Joao Goncalves, and Pedro M P Gois, and Solange Gil, and Luís Tavares, and Frederico Aires-da-Silva
November 2016, ACS medicinal chemistry letters,
Ana S André, and Joana N R Dias, and Sandra Aguiar, and Sara Nogueira, and Pedro Bule, and Joana Inês Carvalho, and João P M António, and Marco Cavaco, and Vera Neves, and Soraia Oliveira, and Gonçalo Vicente, and Belmira Carrapiço, and Berta São Braz, and Barbara Rütgen, and Lurdes Gano, and João D G Correia, and Miguel Castanho, and Joao Goncalves, and Pedro M P Gois, and Solange Gil, and Luís Tavares, and Frederico Aires-da-Silva
May 2024, International journal of pharmaceutics,
Ana S André, and Joana N R Dias, and Sandra Aguiar, and Sara Nogueira, and Pedro Bule, and Joana Inês Carvalho, and João P M António, and Marco Cavaco, and Vera Neves, and Soraia Oliveira, and Gonçalo Vicente, and Belmira Carrapiço, and Berta São Braz, and Barbara Rütgen, and Lurdes Gano, and João D G Correia, and Miguel Castanho, and Joao Goncalves, and Pedro M P Gois, and Solange Gil, and Luís Tavares, and Frederico Aires-da-Silva
February 2021, Journal of clinical medicine,
Ana S André, and Joana N R Dias, and Sandra Aguiar, and Sara Nogueira, and Pedro Bule, and Joana Inês Carvalho, and João P M António, and Marco Cavaco, and Vera Neves, and Soraia Oliveira, and Gonçalo Vicente, and Belmira Carrapiço, and Berta São Braz, and Barbara Rütgen, and Lurdes Gano, and João D G Correia, and Miguel Castanho, and Joao Goncalves, and Pedro M P Gois, and Solange Gil, and Luís Tavares, and Frederico Aires-da-Silva
November 2023, Antibodies (Basel, Switzerland),
Ana S André, and Joana N R Dias, and Sandra Aguiar, and Sara Nogueira, and Pedro Bule, and Joana Inês Carvalho, and João P M António, and Marco Cavaco, and Vera Neves, and Soraia Oliveira, and Gonçalo Vicente, and Belmira Carrapiço, and Berta São Braz, and Barbara Rütgen, and Lurdes Gano, and João D G Correia, and Miguel Castanho, and Joao Goncalves, and Pedro M P Gois, and Solange Gil, and Luís Tavares, and Frederico Aires-da-Silva
April 2021, European journal of medicinal chemistry,
Ana S André, and Joana N R Dias, and Sandra Aguiar, and Sara Nogueira, and Pedro Bule, and Joana Inês Carvalho, and João P M António, and Marco Cavaco, and Vera Neves, and Soraia Oliveira, and Gonçalo Vicente, and Belmira Carrapiço, and Berta São Braz, and Barbara Rütgen, and Lurdes Gano, and João D G Correia, and Miguel Castanho, and Joao Goncalves, and Pedro M P Gois, and Solange Gil, and Luís Tavares, and Frederico Aires-da-Silva
May 2018, Cancer research,
Ana S André, and Joana N R Dias, and Sandra Aguiar, and Sara Nogueira, and Pedro Bule, and Joana Inês Carvalho, and João P M António, and Marco Cavaco, and Vera Neves, and Soraia Oliveira, and Gonçalo Vicente, and Belmira Carrapiço, and Berta São Braz, and Barbara Rütgen, and Lurdes Gano, and João D G Correia, and Miguel Castanho, and Joao Goncalves, and Pedro M P Gois, and Solange Gil, and Luís Tavares, and Frederico Aires-da-Silva
October 2021, Antibodies (Basel, Switzerland),
Ana S André, and Joana N R Dias, and Sandra Aguiar, and Sara Nogueira, and Pedro Bule, and Joana Inês Carvalho, and João P M António, and Marco Cavaco, and Vera Neves, and Soraia Oliveira, and Gonçalo Vicente, and Belmira Carrapiço, and Berta São Braz, and Barbara Rütgen, and Lurdes Gano, and João D G Correia, and Miguel Castanho, and Joao Goncalves, and Pedro M P Gois, and Solange Gil, and Luís Tavares, and Frederico Aires-da-Silva
January 2022, Lung cancer (Amsterdam, Netherlands),
Ana S André, and Joana N R Dias, and Sandra Aguiar, and Sara Nogueira, and Pedro Bule, and Joana Inês Carvalho, and João P M António, and Marco Cavaco, and Vera Neves, and Soraia Oliveira, and Gonçalo Vicente, and Belmira Carrapiço, and Berta São Braz, and Barbara Rütgen, and Lurdes Gano, and João D G Correia, and Miguel Castanho, and Joao Goncalves, and Pedro M P Gois, and Solange Gil, and Luís Tavares, and Frederico Aires-da-Silva
September 2018, Journal of cellular physiology,
Copied contents to your clipboard!